Capstan’s mission is to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA-based therapies.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $175M
Founded date: 2021
Investors 3
| Date | Name | Website |
| 13.04.2024 | Vida Ventu... | vidaventur... |
| 23.03.2024 | Forbion | forbion.co... |
| 30.08.2023 | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.03.2024 | Series B | $175M | Forbion |
Mentions in press and media 7
| Date | Title | Description | Source |
| 22.03.2024 | Capstan Therapeutics Secures $175M in Series B Financing wit... | Capstan Therapeutics, a biotechnology company on the cutting edge of in vivo cell reprogramming, has... | parsers.vc... |
| 21.03.2024 | Capstan Therapeutics Raises $175M in Series B Financing | Capstan Therapeutics, a San Diego, CA-based biotechnology company dedicated to advancing in vivo rep... | finsmes.co... |
| 20.03.2024 | Capstan Therapeutics completes $175M Series B funding to adv... | - | connect.or... |
| 20.03.2024 | Forbion Invests in Capstan Therapeutics with participation i... | • Nanna Luneborg, PhD, MBA, General Partner at Forbion to join Capstan Board of Directors • Capstan ... | forbion.co... |
| 20.03.2024 | Capstan Therapeutics Announces $175M Oversubscribed Series B... | - | vidaventur... |
| - | Capstan Therapeutics | “Our core platform technology pertains to proprietary targeted lipid nanoparticles (tLNPs) that are ... | fastfounde... |
| - | Capstan Therapeutics | “Enabling precise in vivo engineering of cells with payloads necessary to benefit patients across mu... | fastfounde... |